These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 10477522)

  • 1. Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs.
    Jomaa H; Wiesner J; Sanderbrand S; Altincicek B; Weidemeyer C; Hintz M; Türbachova I; Eberl M; Zeidler J; Lichtenthaler HK; Soldati D; Beck E
    Science; 1999 Sep; 285(5433):1573-6. PubMed ID: 10477522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Planting the seeds of new antimalarial drugs.
    Ridley RG
    Science; 1999 Sep; 285(5433):1502-3. PubMed ID: 10498534
    [No Abstract]   [Full Text] [Related]  

  • 3. Non-mevalonate isoprenoid biosynthesis: enzymes, genes and inhibitors.
    Lichtenthaler HK
    Biochem Soc Trans; 2000 Dec; 28(6):785-9. PubMed ID: 11171208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reverse fosmidomycin derivatives against the antimalarial drug target IspC (Dxr).
    Behrendt CT; Kunfermann A; Illarionova V; Matheeussen A; Pein MK; Gräwert T; Kaiser J; Bacher A; Eisenreich W; Illarionov B; Fischer M; Maes L; Groll M; Kurz T
    J Med Chem; 2011 Oct; 54(19):6796-802. PubMed ID: 21866890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alkoxycarbonyloxyethyl ester prodrugs of FR900098 with improved in vivo antimalarial activity.
    Ortmann R; Wiesner J; Reichenberg A; Henschker D; Beck E; Jomaa H; Schlitzer M
    Arch Pharm (Weinheim); 2005 Jul; 338(7):305-14. PubMed ID: 15996004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antiplasmodial activity of highly active reverse analogues of the antimalarial drug candidate fosmidomycin.
    Behrendt CT; Kunfermann A; Illarionova V; Matheeussen A; Gräwert T; Groll M; Rohdich F; Bacher A; Eisenreich W; Fischer M; Maes L; Kurz T
    ChemMedChem; 2010 Oct; 5(10):1673-6. PubMed ID: 20718073
    [No Abstract]   [Full Text] [Related]  

  • 7. A second target of the antimalarial and antibacterial agent fosmidomycin revealed by cellular metabolic profiling.
    Zhang B; Watts KM; Hodge D; Kemp LM; Hunstad DA; Hicks LM; Odom AR
    Biochemistry; 2011 May; 50(17):3570-7. PubMed ID: 21438569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-Deoxy-D-xylulose 5-phosphate reductoisomerase: an overview.
    Proteau PJ
    Bioorg Chem; 2004 Dec; 32(6):483-93. PubMed ID: 15530989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies addressing the importance of charge in the binding of fosmidomycin-like molecules to deoxyxylulosephosphate reductoisomerase.
    Perruchon J; Ortmann R; Altenkämper M; Silber K; Wiesner J; Jomaa H; Klebe G; Schlitzer M
    ChemMedChem; 2008 Aug; 3(8):1232-41. PubMed ID: 18470849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apicoplast isoprenoid precursor synthesis and the molecular basis of fosmidomycin resistance in Toxoplasma gondii.
    Nair SC; Brooks CF; Goodman CD; Sturm A; McFadden GI; Sundriyal S; Anglin JL; Song Y; Moreno SN; Striepen B
    J Exp Med; 2011 Jul; 208(7):1547-59. PubMed ID: 21690250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 1-deoxy-D-xylulose 5-phosphate reductoisomerase catalyzing the formation of 2-C-methyl-D-erythritol 4-phosphate in an alternative nonmevalonate pathway for terpenoid biosynthesis.
    Takahashi S; Kuzuyama T; Watanabe H; Seto H
    Proc Natl Acad Sci U S A; 1998 Aug; 95(17):9879-84. PubMed ID: 9707569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The non-mevalonate isoprenoid biosynthesis of plants as a test system for new herbicides and drugs against pathogenic bacteria and the malaria parasite.
    Lichtenthaler HK; Zeidler J; Schwender J; Müller C
    Z Naturforsch C J Biosci; 2000; 55(5-6):305-13. PubMed ID: 10928537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The malarial drug target Plasmodium falciparum 1-deoxy-D-xylulose-5-phosphate reductoisomerase (PfDXR): development of a 3-D model for identification of novel, structural and functional features and for inhibitor screening.
    Goble JL; Adendorff MR; de Beer TA; Stephens LL; Blatch GL
    Protein Pept Lett; 2010 Jan; 17(1):109-20. PubMed ID: 20214634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reverse
    Abdullaziz MA; Takada S; Illarionov B; Pessanha de Carvalho L; Sakamoto Y; Höfmann S; Knak T; Kiffe-Delf AL; Mazzone F; Pfeffer K; Kalscheuer R; Bacher A; Held J; Fischer M; Tanaka N; Kurz T
    ACS Infect Dis; 2024 May; 10(5):1739-1752. PubMed ID: 38647213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiology of malaria in Cameroon. XXV. In vitro activity of fosmidomycin and its derivatives against fresh clinical isolates of Plasmodium falciparum and sequence analysis of 1-deoxy-D-xylulose 5-phosphate reductoisomerase.
    Tahar R; Basco LK
    Am J Trop Med Hyg; 2007 Aug; 77(2):214-20. PubMed ID: 17690389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tools for discovery of inhibitors of the 1-deoxy-D-xylulose 5-phosphate (DXP) synthase and DXP reductoisomerase: an approach with enzymes from the pathogenic bacterium Pseudomonas aeruginosa.
    Altincicek B; Hintz M; Sanderbrand S; Wiesner J; Beck E; Jomaa H
    FEMS Microbiol Lett; 2000 Sep; 190(2):329-33. PubMed ID: 11034300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structures of Mycobacterium tuberculosis 1-deoxy-D-xylulose-5-phosphate reductoisomerase provide new insights into catalysis.
    Henriksson LM; Unge T; Carlsson J; Aqvist J; Mowbray SL; Jones TA
    J Biol Chem; 2007 Jul; 282(27):19905-16. PubMed ID: 17491006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double ester prodrugs of FR900098 display enhanced in-vitro antimalarial activity.
    Wiesner J; Ortmann R; Jomaa H; Schlitzer M
    Arch Pharm (Weinheim); 2007 Dec; 340(12):667-9. PubMed ID: 17994601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fosmidomycin for the treatment of malaria.
    Wiesner J; Borrmann S; Jomaa H
    Parasitol Res; 2003 Jun; 90 Suppl 2():S71-6. PubMed ID: 12937969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diaryl ester prodrugs of FR900098 with improved in vivo antimalarial activity.
    Reichenberg A; Wiesner J; Weidemeyer C; Dreiseidler E; Sanderbrand S; Altincicek B; Beck E; Schlitzer M; Jomaa H
    Bioorg Med Chem Lett; 2001 Mar; 11(6):833-5. PubMed ID: 11277531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.